Will a senolytic drug be used clinically for any purpose by the end of 2028? | Manifold

Will a senolytic drug be used clinically for any purpose by the end of 2028?

Basic

10

Ṁ276

2029

58%

chance

1D

1W

1M

ALL

The Daily Mail interviews Andrew Steele, the author of Ageless: The New Science of Getting Older Without Getting Old. Steele makes a couple of key predictions in the interview:

"I'd be shocked if in five years we don't have some senolytics in the clinic. It probably won't be for aging at first. It'll be for a specific disease - and maybe in 10 years, we'll use it for aging. These things are very, very near term."

This market is conerned with the first of those predictions: Clinical use of senolytics in humans for any purpose by 2028 (within 5 years of 2023). Senolytics are simply drugs whose mechanism of action is the destruction of senescent cells.

Resolves YES if credible news articles or medical journals describe the successful clinical use of a new senolytic drug outside of trials before the end date. Resolves NO otherwise. I will not be betting in this market.

This question is managed and resolved by Manifold.

Get

1,000

and

3.00

Sort by:

Betting NO just from the low base rate of success of claims about something entering the clinic in near future.

mfw this is trading lower

Since it doesn't look like I ever linked it in, here's the companion market for the second half of Steele's statement (clinical use for treating aging within 10 years):

Related questions

Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?

The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)

Will a drug to be used by most healthy adults be approved by 2043 year end?

Will any company successfully develop a therapeutic treatment that rejuvenates healthspan by at least 10 years by 2030?

Will a drug that didn't go through human clinical trials be approved by 2034?

Will anti-aging treatments developed, approved and available for public usage by 2040?

Will a drug designed with significant contribution from an AlphaFold-like system pass a Phase I trial by end of 2025?

Will an AI-designed drug get FDA approval by the end of 2025?

Will any NLRP3 inhibitor drug be approved in 2023?

Will artificial blood be used to treat a patient by the end of 2028?

Related questions

Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?

Will anti-aging treatments developed, approved and available for public usage by 2040?

The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)

Will a drug designed with significant contribution from an AlphaFold-like system pass a Phase I trial by end of 2025?

Will a drug to be used by most healthy adults be approved by 2043 year end?

Will an AI-designed drug get FDA approval by the end of 2025?

Will any company successfully develop a therapeutic treatment that rejuvenates healthspan by at least 10 years by 2030?

Will any NLRP3 inhibitor drug be approved in 2023?

Will a drug that didn't go through human clinical trials be approved by 2034?

Will artificial blood be used to treat a patient by the end of 2028?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules